Trophos Completes Enrolment Of Phase II Clinical Trial Of TRO19622 In Painful Peripheral Diabetic Neuropathy Trophos SA, a biopharmaceutical company specializing in the discovery and development of
drugs for neurological disorders, announced that it has completed the enrolment of 180 patients in a Phase IIa clinical trial of its of lead product, TRO19622. The randomized, double-blind, placebo-controlled, single dose study will compare the efficacy of TRO19622 to placebo after 6 weeks of treatment in patients with painful diabetic neuropathy.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 5:00 AM
